Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 18, 2019 08:00 ET | Source: H-CYTE, Inc.

H-CYTE Raises $6 Million to Accelerate FDA Approval Process of Next Generation Cellular Therapy for COPD

TAMPA, Fla., Nov. 18, 2019 (GLOBE NEWSWIRE) -- H-CYTE Inc. (OTCQB: HCYT) the owner and operator of innovative medical technology products and services including LungCYTE and Lung Health Institute,...
July 30, 2019 08:00 ET | Source: H-CYTE, Inc.

H-CYTE Bolsters Board of Directors With Appointment of Dr. Atta Behfar to its Board of Directors

TAMPA, Fla., July 30, 2019 (GLOBE NEWSWIRE) -- H-CYTE Inc. (OTCQB: HCYT) (“H-CYTE” or the “Company”), the owner and operator of innovative medical technology products and services including Lung...
July 29, 2019 08:00 ET | Source: H-CYTE, Inc.

H-CYTE Bolsters Board of Directors With Appointment of Dr. Andre Terzic to Board of Directors

TAMPA, Fla., July 29, 2019 (GLOBE NEWSWIRE) -- H-CYTE Inc. (OTCQB: HCYT) (“H-CYTE” or the “Company”), the owner and operator of innovative medical technology products and services including Lung...
July 12, 2019 08:30 ET | Source: Medovex Corp.

Medovex Corporation Announces Name Change to H-CYTE and New Ticker Symbol

TAMPA, Fla., July 12, 2019 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB: MDVX), today announced that FINRA has approved the effectiveness of a change in the company’s name from “Medovex Corp.” to...
July 01, 2019 08:00 ET | Source: Medovex Corp.

Medovex Corporation Updates Name Change and Full Rebranding to H-CYTE

TAMPA, Fla., July 01, 2019 (GLOBE NEWSWIRE) -- Medovex Corp. (OTCQB: MDVX), today updated investors on its name change and rebranding to H-CYTE. The announcement underscores the Company's broader...